BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33234848)

  • 1. MicroRNAs expression associated with aggressive clinicopathological features and poor prognosis in primary cutaneous melanomas.
    Murria Estal R; de Unamuno Bustos B; Pérez Simó G; Simarro Farinos J; Torres Navarro I; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
    Melanoma Res; 2021 Feb; 31(1):18-26. PubMed ID: 33234848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.
    Valentini V; Zelli V; Gaggiano E; Silvestri V; Rizzolo P; Bucalo A; Calvieri S; Grassi S; Frascione P; Donati P; Soda G; Ottini L; Richetta AG
    Anticancer Res; 2019 Aug; 39(8):4085-4093. PubMed ID: 31366492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary study of microRNA expression in different types of primary melanoma.
    Gencia I; Baderca F; Avram S; Gogulescu A; Marcu A; Seclaman E; Marian C; Solovan C
    Bosn J Basic Med Sci; 2020 May; 20(2):197-208. PubMed ID: 31479413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.
    de Unamuno Bustos B; Murria Estal R; Pérez Simó G; Simarro Farinos J; Pujol Marco C; Navarro Mira M; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
    Br J Dermatol; 2018 Aug; 179(2):394-404. PubMed ID: 29278418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the Prognostic Role of MicroRNAs in Cutaneous Melanoma.
    Dika E; Riefolo M; Porcellini E; Broseghini E; Ribero S; Senetta R; Osella-Abate S; Scarfì F; Lambertini M; Veronesi G; Patrizi A; Fanti PA; Ferracin M
    J Invest Dermatol; 2020 Nov; 140(11):2260-2267. PubMed ID: 32275975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of microRNAs associated with invasive and aggressive phenotype in cutaneous melanoma by next-generation sequencing.
    Babapoor S; Wu R; Kozubek J; Auidi D; Grant-Kels JM; Dadras SS
    Lab Invest; 2017 Jun; 97(6):636-648. PubMed ID: 28218741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
    Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
    Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of microRNAs and their target genes in melanomas originating from gynecologic sites.
    DiVincenzo MJ; Angell CD; Suarez-Kelly LP; Ren C; Barricklow Z; Moufawad M; Fadda P; Yu L; Backes FJ; Ring K; Mills A; Slingluff C; Chung C; Gru AA; Carson WE
    PLoS One; 2023; 18(6):e0285804. PubMed ID: 37384650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-10b is a prognostic biomarker for melanoma.
    Saldanha G; Elshaw S; Sachs P; Alharbi H; Shah P; Jothi A; Pringle JH
    Mod Pathol; 2016 Feb; 29(2):112-21. PubMed ID: 26743475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis.
    Dika E; Broseghini E; Porcellini E; Lambertini M; Riefolo M; Durante G; Loher P; Roncarati R; Bassi C; Misciali C; Negrini M; Rigoutsos I; Londin E; Patrizi A; Ferracin M
    Cell Death Dis; 2021 May; 12(5):473. PubMed ID: 33980826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in microRNA expression between melanoma and healthy adjacent skin.
    Aksenenko M; Palkina N; Komina A; Tashireva L; Ruksha T
    BMC Dermatol; 2019 Jan; 19(1):1. PubMed ID: 30611259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy.
    Ecke TH; Stier K; Weickmann S; Zhao Z; Buckendahl L; Stephan C; Kilic E; Jung K
    Cancer Med; 2017 Oct; 6(10):2252-2262. PubMed ID: 28879675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of circulating MiR-30b-5p identifies advanced breast cancer.
    Estevão-Pereira H; Lobo J; Salta S; Amorim M; Lopes P; Cantante M; Reis B; Antunes L; Castro F; Palma de Sousa S; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
    J Transl Med; 2019 Dec; 17(1):435. PubMed ID: 31888645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
    Kitago M; Martinez SR; Nakamura T; Sim MS; Hoon DS
    Clin Cancer Res; 2009 May; 15(9):2988-94. PubMed ID: 19336521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis.
    Tembe V; Schramm SJ; Stark MS; Patrick E; Jayaswal V; Tang YH; Barbour A; Hayward NK; Thompson JF; Scolyer RA; Yang YH; Mann GJ
    Pigment Cell Melanoma Res; 2015 May; 28(3):254-66. PubMed ID: 25490969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of miR-146a-5p and miR-21-5p with Prognostic Features in Melanomas.
    Naddeo M; Broseghini E; Venturi F; Vaccari S; Corti B; Lambertini M; Ricci C; Fontana B; Durante G; Pariali M; Scotti B; Milani G; Campione E; Ferracin M; Dika E
    Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular networks and mechanisms of epithelial-mesenchymal transition regulated by miRNAs in the malignant melanoma cell line].
    Wang D; Li YJ; Ding N; Wang JY; Yang Q; Yang YR; Li YM; Fang XD; Zhao H
    Yi Chuan; 2015 Jul; 37(7):673-82. PubMed ID: 26351167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of microRNA-106b and its clinical significance in cutaneous melanoma.
    Lin N; Zhou Y; Lian X; Tu Y
    Genet Mol Res; 2015 Dec; 14(4):16379-85. PubMed ID: 26662433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global microRNA profiling for diagnostic appraisal of melanocytic Spitz tumors.
    Latchana N; Regan K; Howard JH; Aldrink JH; Ranalli MA; Peters SB; Zhang X; Gru A; Payne PRO; Suarez-Kelly LP; Carson WE
    J Surg Res; 2016 Oct; 205(2):350-358. PubMed ID: 27664883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.